Meilin Liu

Meilin Liu

Auto-generated profile, based on publicly available information

Meilin Liu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2024 in The FASEB Journal
Verified
Journal Article
Open access
NLNana Li
Nana Li
NXNi Xia
Ni Xia
JHjunyi he
junyi he
MLMeilin Liu
Meilin Liu
MGMuyang Gu
Muyang Gu
XCXiang Cheng
Xiang Cheng
Myocardial infarction (MI) is defined as sudden ischemic death of myocardial tissue. Amphiregulin (Areg) regulates cell survival and is crucial for the healing of tissues after damage. However, the functions and mechanisms of Areg after MI remain unclear. Here, we aimed to investigate Areg's impact on myocardial remodeling. Mice model of MI was constructed and Areg −/− mice were used. Expression of Areg was analyzed using western blotting, RT–qPCR, flow cytometry, and immunofluorescence staining. Echocardiographic analysis, Masson's trichrome, and triphenyltetrazolium chloride staining were used to assess cardiac function and structure. RNA sequencing was used for unbiased analysis. Apoptosis and autophagy were determined by western blotting, TUNEL staining, electron microscopy, and mRFP‐GFP‐LC3 lentivirus. Lysosomal acidity was determined by Lysotracker staining. Areg was elevated in the infarct border zone after MI. It was mostly secreted by macrophages. Areg deficiency aggravated adverse ventricular remodeling, as reflected by worsening cardiac function, a lower survival rate, increased scar size, and interstitial fibrosis. RNA sequencing analyses showed that Areg related to the epidermal growth factor receptor (EGFR), phosphoinositide 3‐kinase/protein kinase B (PI3K‐Akt), mammalian target of rapamycin (mTOR) signaling pathways, V‐ATPase and lysosome pathways. Mechanistically, Areg exerts beneficial effects via increasing lysosomal acidity to promote autophagosome clearance, and activating the EGFR/PI3K/Akt/mTOR signaling pathway, subsequently inhibiting excessive autophagosome formation and apoptosis in cardiomyocytes. This study provides a novel evidence for the role of Areg in inhibiting ventricular remodeling after MI by regulating autophagy and apoptosis and identifies Areg as a potential therapeutic target in ventricular remodeling after MI.

1 April 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MZMin Zhang
Min Zhang
TZTing Zhou
Ting Zhou
MLMeilin Liu
Meilin Liu
NXNi Xia
Ni Xia
MGMuyang Gu
Muyang Gu
XCXiang Cheng
Xiang Cheng

23 July 2024 in JACC: Asia
Verified
Journal Article
Open access
MYMiao Yu
Miao Yu
YYYuan-Fan Yuan
Yuan-Fan Yuan
FYFen Yang
Fen Yang
JXJia-Hao Xu
Jia-Hao Xu
MLMei-Lin Liu
Mei-Lin Liu
XCXiang Cheng
Xiang Cheng

7 March 2026 in JACC: Asia
Verified
Journal Article
Open access
YXYu-Yan Xiong
Yu-Yan Xiong
MYMiao Yu
Miao Yu
QLQi Long
Qi Long
FYFen Yang
Fen Yang
YYYuan-Fan Yuan
Yuan-Fan Yuan
XCXiang Cheng
Xiang Cheng
Although abundant data support an association between C-reactive protein (CRP) concentration and poor prognosis in coronary heart disease (CHD) patients in Western countries, East Asian populations with lower baseline CRP levels require further comprehensive evaluation. This systematic review and meta-analysis aimed to clarify the inflammatory risk cutoff value of CRP level in East Asian CHD patients and the association between CRP level and the risk of major adverse cardiovascular events (MACE). We conducted a systematic review by searching PubMed, Embase, Cochrane Library, and Scopus from their inception to June 7, 2025. Studies that met the criteria reported the association between CRP level and incidence of MACE, a composite of all-cause death, myocardial infarction, stroke, and revascularization. Eight studies, which collectively involved 21,455 patients, met the inclusion criteria. Elevated CRP levels were found to be notably associated with an increased MACE risk (RR: 1.41, 95% CI: 1.22-1.63; P < 0.00001; I2 = 69%). Subgroup analysis further revealed that the median CRP level in East Asian CHD patients was 1.2 mg/L, which was much lower than that in Western populations. Moreover, the CRP level ≥1.0 mg/L rather than ≥2.0 mg/L better predicted poor prognosis in East Asian patients. This meta-analysis indicates that the median CRP level among East Asian CHD patients is 1.2 mg/L. Furthermore, a CRP level ≥1.0 mg/L can appropriately define inflammatory risk and serves as a suitable predictor of poor prognosis in East Asian CHD patients.

19 December 2023 in The FASEB Journal
Verified
Journal Article
Open access
MLMeilin Liu
Meilin Liu
NXNi Xia
Ni Xia
LZLingfeng Zha
Lingfeng Zha
HYHaoyi Yang
Haoyi Yang
MGMuyang Gu
Muyang Gu
XCXiang Cheng
Xiang Cheng
CD4+ T‐cell counts are increased and activated in patients with chronic heart failure (CHF), whereas regulatory T‐cell (Treg) expansion is inhibited, probably due to aberrant T‐cell receptor (TCR) signaling. TCR signaling is affected by protein tyrosine phosphatase nonreceptor type 22 (PTPN22) in autoimmune disorders, but whether PTPN22 influences TCR signaling in CHF remains unclear. This observational case–control study included 45 patients with CHF [18 patients with ischemic heart failure versus 27 patients with nonischemic heart failure (NIHF)] and 16 non‐CHF controls. We used flow cytometry to detect PTPN22 expression, tyrosine phosphorylation levels, zeta‐chain‐associated protein kinase, 70 kDa (ZAP‐70) inhibitory residue tyrosine 292 and 319 phosphorylation levels, and CD4+ T cell and Treg proportions. We conducted lentivirus‐mediated PTPN22 RNA silencing in isolated CD4+ T cells. PTPN22 expression increased in the CD4+ T cells of patients with CHF compared with that in controls. PTPN22 expression was positively correlated with left ventricular end‐diastolic diameter and type B natriuretic peptide but negatively correlated with left ventricular ejection fraction in the NIHF group. ZAP‐70 tyrosine 292 phosphorylation was decreased, which correlated positively with PTPN22 overexpression in patients with NIHF and promoted early TCR signaling. PTPN22 silencing induced Treg differentiation in CD4+ T cells from patients with CHF, which might account for the reduced frequency of peripheral Tregs in these patients. PTPN22 is a potent immunomodulator in CHF and might play an essential role in the development of CHF by promoting early TCR signaling and impairing Treg differentiation from CD4+ T cells.